Drug Selectivity
Jörg Holenz
New Drug Development for Known and Emerging Viruses
Biomolecular Simulations in Structure-Based Drug Discovery
Early Drug Development
Lead Generation
Target Discovery and Validation
Epigenetic Drug Discovery
Flow and Microreactor Technology in Medi
Flow and Microreactor Technology in Medicinal Chemistry
Neglected Tropical Diseases
Innovative Dosage Forms
Targeted Drug Delivery
RNA As a Drug Target
Lead Optimization
Drug Development Approaches for Poorly S
Drug Development Approaches for Poorly Soluble Compounds
Antidepressants, Antipsychotics, Anxioly
Antidepressants, Antipsychotics, Anxiolytics
Targeting RNA with Small Molecules
Antidepressants, Antipsychotics, Anxiolytics, 2 Volume Set From Chemistry and Pharmacology to Clinical Application
